LYNK Pharmaceuticals
3 known investors
Lynk Pharmaceuticals is a clinical-stage drug company developing small-molecule therapies for autoimmune and inflammatory diseases, targeting JAK-STAT and TYK2 signaling pathways and using targeted protein degradation to create oral alternatives to biologics. It runs an AI-assisted drug design and R&D platform covering target discovery through clinical development.
AI & Machine LearningBiotechHealthtech
Investors · 3
Frequently asked questions
- What does LYNK Pharmaceuticals do?
- Lynk Pharmaceuticals is a clinical-stage drug company developing small-molecule therapies for autoimmune and inflammatory diseases, targeting JAK-STAT and TYK2 signaling pathways and using targeted protein degradation to create oral alternatives to biologics. It runs an AI-assisted drug design and R&D platform covering target discovery through clinical development.
- Who are LYNK Pharmaceuticals's investors?
- LYNK Pharmaceuticals's investors include Decheng Capital, LAV, Lilly Asia Ventures.